News & Events :: Vivani Medical, Inc. (VANI)

Press ReleasesView All News

Sep 4, 2025 8:30am EDT

Vivani Medical Provides Update on Clinical Development Plans for NPM-139 Semaglutide Implant for Chronic Weight Management

Aug 20, 2025 8:30am EDT

Vivani Medical CEO Adam Mendelsohn to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025

View All Press Releases

In The News View All In The News

Mar 13, 2025

CEO Dr. Adam Mendelsohn and CBO Don Dwyer participated in a Vivani-hosted investor conference call to discuss recent progress in the LIBERATE-1 clinical trial

Sep 25, 2024

CEO Dr. Adam Mendelsohn presented at the Emerging Growth Conference on September 25, 2024.

Sep 24, 2024

CEO Dr. Adam Mendelsohn joined Daniel Levine on the September 24, 2024 installment of The Bio Report podcast to discuss Vivani Medical’s implantable drug delivery technology, how it works, and why its lead indication is a GLP-1 implant for weight loss and diabetes.

View All In The News

Recent Events View All Events

September 10, 2025 1:00 pm EDT – 1:30 pm EDT

H.C. Wainwright 27th Annual Global Investment Conference

View All Events

Latest Presentation

Sep 9, 2025

2025 Investor Presentation

View All Presentations

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings